{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:31:43Z","timestamp":1774128703433,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008907","name":"Oklahoma Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010285","name":"University of San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AR060804"],"award-info":[{"award-number":["P50AR060804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR065953"],"award-info":[{"award-number":["R01AR065953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR073855"],"award-info":[{"award-number":["R01AR073855"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR074310"],"award-info":[{"award-number":["R01AR074310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.clim.2023.109243","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T01:52:20Z","timestamp":1674525140000},"page":"109243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anti-vimentin antibodies are associated with higher severity of Sj\u00f6gren's disease"],"prefix":"10.1016","volume":"247","author":[{"given":"Harini","family":"Bagavant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina M.","family":"Araszkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Pezant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Hal","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Darise","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh S.","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109243_bb0005","author":"The Human Protein Atlas"},{"issue":"10","key":"10.1016\/j.clim.2023.109243_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/cells7100147","article-title":"Vimentin diversity in health and disease","volume":"7","author":"Danielsson","year":"2018","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.clim.2023.109243_bb0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.clim.2023.109243_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.55563\/clinexprheumatol\/3y0hqs","article-title":"Sj\u00f6gren\u2019s syndrome and other rare and complex connective tissue diseases: an intriguing liaison","volume":"40 Suppl 134","author":"Baldini","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2023.109243_bb0025","first-page":"558","article-title":"Antibodies to cytoplasmic intermediate filaments in rheumatic diseases","volume":"10","author":"Kurki","year":"1983","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2023.109243_bb0030","first-page":"1658","article-title":"Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis","volume":"34","author":"So\u00f3s","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","article-title":"Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis","volume":"34","author":"Poulsom","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.clim.2023.109243_bb0040","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","article-title":"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy","volume":"10","author":"Nicaise Roland","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.clim.2023.109243_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3899\/jrheum.080656","article-title":"Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis","volume":"36","author":"Mutlu","year":"2009","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2023.109243_bb0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.080796","article-title":"The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis","volume":"36","author":"Liu","year":"2009","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2023.109243_bb0055","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.clim.2023.109243_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2011.10.020","article-title":"Mutated citrullinated vimentin antibodies in rheumatoid arthritis","volume":"413","author":"Kuna","year":"2012","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2013-203845","article-title":"Comparison of the American-European consensus group Sjogren\u2019s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort","volume":"73","author":"Rasmussen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109243_bb0075","article-title":"Systemic immune response to vimentin and granuloma formation in a model of pulmonary sarcoidosis","volume":"5","author":"Bagavant","year":"2022","journal-title":"J. Transl. Autoimm."},{"issue":"3","key":"10.1016\/j.clim.2023.109243_bb0080","first-page":"80","article-title":"Minor salivary gland fibrosis in Sj\u00f6gren\u2019s syndrome is elevated, associated with focus score and not solely a consequence of aging","volume":"36 Suppl 112","author":"Leehan","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2023.109243_bb0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sj\u00f6gren\u2019s Syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13075-017-1508-5","article-title":"Identification of a novel autoantibody against self-vimentin specific in secondary Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Li","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","article-title":"Vimentin is secreted by activated macrophages","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"20","key":"10.1016\/j.clim.2023.109243_bb0100","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1128\/MCB.24.20.9198-9206.2004","article-title":"The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature","volume":"24","author":"Xu","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.clim.2023.109243_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029305","article-title":"Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface","volume":"6","author":"P\u00e4ll","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109243_bb0110","doi-asserted-by":"crossref","first-page":"1965935","DOI":"10.1155\/2018\/1965935","article-title":"The TGF-\u03b21 signaling pathway as an attractive target in the fibrosis pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"2018","author":"Sisto","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.clim.2023.109243_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cei.13337","article-title":"Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sj\u00f6gren\u2019s syndrome","volume":"198","author":"Sisto","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2023.109243_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00005-020-00591-5","article-title":"IL-6 contributes to the TGF-\u03b21-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells","volume":"68","author":"Sisto","year":"2020","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"3","key":"10.1016\/j.clim.2023.109243_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-2478(01)00344-3","article-title":"Identification of candidate genes for Sj\u00f6gren\u2019s syndrome using MRL\/lpr mouse model of Sj\u00f6gren\u2019s syndrome and cDNA microarray analysis","volume":"81","author":"Azuma","year":"2002","journal-title":"Immunol. Lett."},{"issue":"7","key":"10.1016\/j.clim.2023.109243_bb0130","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","article-title":"CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren\u2019s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization","volume":"180","author":"Barone","year":"2008","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"2","key":"10.1016\/j.clim.2023.109243_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3892\/ijo.2012.1499","article-title":"Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1\/CXCR4 axis in intrahepatic cholangiocarcinoma","volume":"41","author":"Okamoto","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2023.109243_bb0140","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2375","article-title":"Biomarker profiles in serum and saliva of experimental Sj\u00f6gren's syndrome: associations with specific autoimmune manifestations","volume":"10","author":"Delaleu","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.clim.2023.109243_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jor.22308","article-title":"The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells","volume":"31","author":"Li","year":"2013","journal-title":"J. Orthop. Res."},{"issue":"11","key":"10.1016\/j.clim.2023.109243_bb0150","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1074\/jbc.M111.322800","article-title":"Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires \u03b2-catenin activation via Akt\/GSK3- and MTA1\/Wnt1 protein-dependent pathways","volume":"287","author":"Yan","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.clim.2023.109243_bb0155","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.1700473","article-title":"Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis","volume":"199","author":"Li","year":"2017","journal-title":"J. Immunol. (Baltim. Md.: 1950)"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:06:33Z","timestamp":1738901193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":31,"alternative-id":["S1521661623000220"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109243","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-vimentin antibodies are associated with higher severity of Sj\u00f6gren's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109243"}}